Presentation is loading. Please wait.

Presentation is loading. Please wait.

항균제 내성률 (2013.2.1~2013.2.28) Table 1. 그람음성균의 항균제 내성률 (%) 균주별 항균제 Escherichia coli Klebsiella pneumoniae Pseudomonas aeruginosaAcinetobacter baumanniiEnterobacter.

Similar presentations


Presentation on theme: "항균제 내성률 (2013.2.1~2013.2.28) Table 1. 그람음성균의 항균제 내성률 (%) 균주별 항균제 Escherichia coli Klebsiella pneumoniae Pseudomonas aeruginosaAcinetobacter baumanniiEnterobacter."— Presentation transcript:

1 항균제 내성률 (2013.2.1~2013.2.28) Table 1. 그람음성균의 항균제 내성률 (%) 균주별 항균제 Escherichia coli Klebsiella pneumoniae Pseudomonas aeruginosaAcinetobacter baumanniiEnterobacter spp ICU 제 외 (82 건 ) ICU (8 건 ) ICU 제외 (39 건 ) ICU (8 건 ) ICU 제외 (23 건 ) ICU (2 건 ) ICU 제외 (14 건 ) ICU (9 건 ) ICU 제 외 (16 건 ) ICU (6 건 ) ESBL(+)/ MDR32.937.551.362.50.0 64.377.8-- Ampicillin(AM)76.887.5100 ---- Amoxicillin/Clavulanic Acid(AMC) 12.237.543.650.0----100 Amikacin(AN)0.0 10.312.526.10.064.377.80.0 Aztreonam(ATM)32.937.551.362.513.00.078.677.825.083.3 Cefazolin(CZ)39.075.064.175.0----100 Ceftazidine(CAZ)35.475.061.575.00.0 64.377.825.083.3 Ciprofloxacin(CIP)45.175.061.587.534.850.064.377.80.0 Colistin(CS)----0.050.00.0 -- Cefotaxime(CTX)36.675.059.062.510050.064.377.831.383.3 Ertapenem(ETP)0.0 15.412.5----6.30.0 Cefepime(FEP)32.937.551.362.54.30.064.377.80.0 Cefoxitin(FOX)20.737.535.937.5----100 Gentamicin(GM)28.025.010.325.030.450.064.377.80.0 Imipenem(IPM)0.0 5.10.021.710064.377.812.50.0 Meropenem(MEM)----4.30.071.477.8-- Piperacillin(PIP)----21.750.064.377.8-- Ampicillin/Sulbactam(SAM)----100 7.111.1-- Trimethoprim/Sulfamethoxazole(SXT) 51.225.041.050.010050.064.377.825.083.3 Piperacillin/Tazobactam(TZP)4.90.059.075.026.10.064.377.80.0 ESBL : Extended Spectrum Beta-Lactamase MDR : Multi-drug Resistant(3 가지 계열 이상의 항생제에 내성 ) 건국대학교 충주병원 감염관리실

2 Table 2. 그람양성균의 항균제 내성률 (%) 균주별 항균제 Staphylococcus aureus Coagulase-negative Staphylococcus Entrococcus faecalisEnterococcus faecium ICU 제외 (37 건 ) ICU (14 건 ) ICU 제외 (30 건 ) ICU (1 건 ) ICU 제외 (33 건 ) ICU (1 건 ) ICU 제외 (14 건 ) ICU (1 건 ) Ciprofloxacin(CIP)54.135.750.00.033.30.0100 Clindamycin(CM)48.628.643.310097.0100 Erythromycin(E)56.828.660.010057.60.0100 Fusidic Acid(FA)43.214.340.0100---- Nitrofurantoin(FT)0.0 42.90.0 Gentamicin(GM)45.914.346.70.0---- Habekacin(HAB)0.0 ---- Gentamicin High Level(HLG)----66.70.078.60.0 Streptomycin High Level(HLS)----24.20.021.40.0 Imipenem(IPM)----0.0 100 Levofloxacin(LEV)----33.30.0100 Linezolid(LNZ)0.0 Mupirocin(MUP)2.70.036.70.0---- Norfloxacin(NOR)----39.40.0100 Oxacillin(OX)70.350.073.30.0---- Penicillin G(P)100 0.048.50.0100 Rifampicin(RA)2.70.03.30.0---- Ampicillin/Sulbactam(SAM)----0.0 92.9100 Trimethoprim/Sulfamethoxazole(SXT)10.80.033.30.0100 Tetracycline(TE)43.27.150.00.090.910042.90.0 Teicoplanin(TEC)0.0 14.3100 Telithromycin(TEL)43.214.323.3100---- Vancomycin(VA)0.0 3.30.0 14.3100 건국대학교 충주병원 감염관리실

3 MRSA : Methicillin-Resistant Staphylococcus aureus VRE : Vancomycin Resistant Enterococci ESBL : Extended Spectrum Beta-Lactamase CIP : Ciprofloxacin

4 건국대학교 충주병원 감염관리실 MDR : Multi-drug Resistant(3 가지 계열 이상의 항생제에 내성 )


Download ppt "항균제 내성률 (2013.2.1~2013.2.28) Table 1. 그람음성균의 항균제 내성률 (%) 균주별 항균제 Escherichia coli Klebsiella pneumoniae Pseudomonas aeruginosaAcinetobacter baumanniiEnterobacter."

Similar presentations


Ads by Google